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Green Fluorescent protein (GFP) from Aequorea ?ictoria was
used as an in vivo reporter protein when fused to the C-terminus
of the Jen1 lactate permease of Saccharomyces cerevisiae. The
Jen1 protein tagged with GFP is a functional lactate transporter
with a cellular abundance of 1670 molecules/cell, and a catalytic-
centre activity of 123 s-1. It is expressed and tagged to the plasma
membrane under induction conditions. The factors involved in
proper localization and turnover of Jen1p were revealed by
expression of the Jen1p-GFP fusion protein in a set of strains
bearing mutations in specific steps of the secretory and endocytic
INTRODUCTION
It has been shown that the product of the gene JEN1 is required
for the uptake of lactate and other monocarboxylates in the yeast
Saccharomyces cerevisiae [1]. To date, this is the first and only
gene known to be involved in monocarboxylate transport in
fungi. An exhaustive study carried out recently revealed that the
S. cerevisiae homologues of mammalian monocarboxylate per-
meases do not transport monocarboxylic acids across the plasma
membrane [2], in contrast with what had been suggested from
computer analyses [3,4]. Jen1p is therefore the only model of a
monocarboxylate transporter in yeast, and its study can provide
important insights into the function of the mammalian monocar-
boxylate transporters (` MCTs '; for a review, see [5]), and of
permeases in general. In the case of plasma membrane proteins,
an effort is being orchestrated by several groups towards the
understanding of their trafficking, localization and degradation.
Previous studies performed in our laboratory have shown that
JEN1 expression is mediated under glucose catabolite repression
at distinct levels : transcription, mRNA turnover and carrier
inactivation [6]. Jen1p is rapidly inactivated on addition of
pathways. The chimaeric protein Jen1p-GFP is targeted to the
plasma membrane via a Sec6-dependent process; upon treatment
with glucose, it is endocytosed via END3 and targeted for
degradation in the vacuole. Experiments performed in a Ddoa4
mutant strain showed that ubiquitination is associated with the
turnover of the permease.
Key words : yeast, transport, secretion, ubiquitination, endo-
cytosis.
Universitat Basel, Basel, Switzerland), was used for the con-
struction of the JEN1-GFP chimaera. The plasmid YEp96,
which contains a synthetic yeast Ubiquitin (Ub) gene under the
control of the copper-inducible CUP1 promoter, was used [8] for
the overexpression of Ub. The cultures were maintained on
slants of 1 % (w/v) yeast extract, 1 % (w/v) peptone, 2 % (w/v)
glucose and  2% (w/v) agar. To promote growth, either a
complex medium containing  1% (w/v) yeast extract and  1%
(w/v) peptone (YP medium) or a synthetic minimal medium
comprising 0.67 % (w/v) Difco yeast nitrogen base, supplemented
with adequate quantities of auxotrophic requirements (YNB
medium), were used. Carbon sources were either glucose (2 %,
w/v) or D,L-lactic acid (0.5 %, v/v; at pH 5.0). Strains
with temperature-sensitive  alleles were grown at  24 °C (the
permis- sive temperature) or  37 °C (the restrictive
temperature); other strains were grown at  30 °C. Cultures
were always harvested
Table 1 Yeast strains used in this paper
glucose to induced cells, undergoing an irreversible catabolic-
inactivation process [6]. In the present study, green fluorescent Strain Genotype Source or reference
protein (GFP) (for a recent review, see [7]) from Aequorea
?ictoria was used as in vivo reporter protein, fused to the C-
terminus of the Jen1 monocarboxylate permease of S. cerevisiae.
Our studies focused on the expression, trafficking and turnover
of Jen1p.
CEN.PK113-5D MATa ura3-52 [8]
CEN.PK 113-13D-Djen1 MATa ura3-52 D jen1 [2]
BLC 491-U2 MATa ura3-52 JEN1 : : GFP Kanr The present work
NY17 MATa sec6-4 ura3-52 [9]
RH1623 MATa his4 leu2 ura3 bar1-1 end3-1 [10]
BLC 492 MATa ura3-52 sec6-4 JEN1 : : GFP Kanr The present work
MATERIALS AND METHODS
Strains, plasmids and growth conditions
The S. cerevisiae strains used in this study are listed in Table 1.
Plasmid pFA6a-GFPS65T-KanMX6, kindly provided by A.
BLC 493 MATa his4 ura3 bar1-1 end3-1
JEN1: GFP Kanr
MHY501 MATa his3-D200 leu2-3,112 ura3-52
lys2-801 trp1
MHY623 MATa his3-D200 ura3-52 lys2-801 trp1
doa4: : LEU2
The present work
[11]
[11]
Wach (Institut fur Angewandte Mikrobiologie, Biozentrum,
Abbreviations used: CMAC-Arg, 7-amino-4-chloromethylcoumaryl-L-arginine amide dihydrochloride ; GFP, green fluorescent protein ; ORF, open
reading frame; Ub, ubiquitin.
1 To whom correspondence should be addressed (e-mail mcasal!bio.uminho.pt).
Table 2 Oligonucleotides used to construct and check the JEN1–GFP
fusion
The 21 underlined nt of primer S1 anneal to the 5«-end of the GFP ORF in plasmid pFA6a-
GFPS65T-KanMX6A. The underlined 19 nt of primer S2 anneal to the 3«-end of the ADH1
terminator in plasmid pFA6a-GFPS65T-KanMX6A.
Oligonucleotide Sequence
S1 5«-GATTCGAACGTCTCAAAGACATATGAGGAGCATATTGAGAC
CGTTAGTAAAGGAGAAGAACTTTTC-3«
S2 5«-GTTACATAGAGAAGCGAACACGCCCTAGAGAGCAATGAAAA
GTGAGGATGGCGGCGTTAGTATC-3«
K2 5«-CGATAGATTGTCGCACCTG-3« K3
5«-CCATCCTATGGAACTGCCTC-3« A1
5«-GGCCTATCCAAGGATGCTGTC-3« A2
5«-GGCCCATTCAGTGCAAGAACC-3«
during the exponential phase of growth. Glucose-containing
media, i.e. YP (YPD) or YNB (YNBD) were used for the growth
of yeast cells under conditions of repression. Conditions for the
induction of yeast were obtained by incubating cells previously
grown under repression conditions in YNB medium with d,l-
lactic acid for 4 h. Media contained 0.1 mM CuSO% for experi-
ments involving overexpression of Ub. Cell growth was moni-
tored by measuring the attenuance (D) of appropriately diluted
cell suspensions at 600 nm.
Genetic methods
Crosses, isolations of diploids, sporulation and tetrad analysis
were achieved using standard methods [13].
JEN1-GFP chimaeric DNA fragment and transformation
A genetic chimaera formed between JEN1 and GFP was made to
yield a fusion gene at the chromosomal JEN1 locus. The flanking
homology PCR cassette technique [14,15] was used. Primer S1
(Table 2) has 46 bp of DNA that are homologous with the 3«-end
of the JEN1 open reading frame (ORF), not including the stop
codon, followed by 21 bp of sequence derived from the 5«-end of
the GFP reporter gene in the plasmid pFA6a-GFPS65T-
KanMX6. Primer S2 (Table 2) has 45 bp DNA homologous with
first 45 nucleotides downstream of the JEN1 ORF, followed by
19 bp of sequence derived from the  3«-end of the ADH1 ter-
minator in the plasmid pFA6a-GFPS65T-KanMX6A. The re-
sulting PCR product of 2.4 kb was purified, and used to transform
cells of the strain CEN.PK 113-5D by the improved lithium-
acetate method [16]. Transformed cells were grown at 30 °C in
YPD media for 4 h and then spread on to YPD plates containing
200 mg/l Geneticin (G418 from Life Technologies; Gaithersburg,
MD, U.S.A.). To purify transformants from the background,
each large colony was re-streaked on to fresh YPD/Geneticin
plates. Only those clones that grew after both means of selection
were analysed further as potentially the sought-after transfor-
mants by analytical PCR, as described by Kruckeberg et al. [17].
Molecular biology techniques were performed using standard
procedures published previously [18].
Transport assays
Cells incubated under de-repressed conditions were harvested by
centrifugation, and washed twice in ice-cold deionized water to a
final concentration of about 25±40 mg dry weight/ml. Conical
centrifuge tubes containing 30 ll of 0.1 M KH2PO% buffer at pH
5.0 and 10 ll of the yeast suspension were incubated for 2 min at
25 °C. The reaction was started by the addition of  10 ll of an
aqueous solution of  4000 d.p.m./nmol of radiolabelled l-[1-
14C]lactic acid (sodium salt; Amersham Biosciences, Piscataway,
NJ, U.S.A.) at pH 5.0. The reaction was stopped by dilution with
5 ml of ice-cold water. The reaction mixtures were filtered
immediately through GF/C membranes (Whatman Biosystems
Ltd., Maidstone, Kent, U.K.) and the filters were washed with
10 ml of ice-cold water and transferred to scintillation fluid
(Opti-Phase HiSafe II; LKB, Gaithersburg, MD, U.S.A.). Radio-
activity was measured in a Packard Tri-Carb  2200 CA liquid
scintillation spectrophotometer equipped with a d.p.m. cor-
rection facility. For non-specific adsorption of 14C, labelled lactic
acid was added at time zero after the cold water. To determine
the best fitting transport kinetics to the experimental initial-
uptake rate values, and to estimate the kinetic parameters, a
computer-assisted non-linear regression analysis (GraphPAD
software; San Diego, CA, U.S.A.) was used. All the experiments
were repeated at least three times, and the data reported represent
the average values.
Microscopy
Living cells were examined with a Leitz Aristoplan epifluores-
cence microscope with filter cube  1001 HQ-FITC (Chroma
Technology, Brattleboro, VT, U.S.A.) for GFP excitation, and
filter A for 7-amino-4-chloromethylcoumaryl-l-arginine amide
dihydrochloride (CMAC-Arg; Molecular Probes, Eugene, OR,
U.S.A.). For staining of vacuolar lumen, cells were incubated
with CMAC-Arg according to the manufacturer's instructions.
For the capture of images, an Apogee charge-coupled-device
camera was used, and the micrographs were processed for
display using Image Pro Plus software.
Cell protein measurement
Total cell protein was measured by the Lowry assay, after the
digestion of cells overnight in 1 M NaOH.
Fluorescence spectroscopy
A Hitachi RF-5001PC fluorimeter was used to scan the excitation
and emission spectra of whole-cell suspensions. Spectra of
cells expressing JEN1±GFP were normalized for cell density,
and were corrected for background by subtraction of spectra that
were recorded for cells expressing JEN1 cultured under identical
conditions. Emission spectra were collected between   500
and  550 nm, with excitation set at  489 nm, and excitation and
emission slit widths of 3 nm.
Catalytic-centre activity and cellular abundance estimation
The catalytic-centre activity and cellular abundance of Jen1±GFP
protein were estimated by the method of Kruckeberg et al. [17].
Immunobloting
Immunoblot analyses were performed following the method of
Kruckeberg et al. [17]. Anti-GFP antibody was purchased from
Molecular Probes, and diluted 1 :500.
RESULTS
Construction of a Jen1–GFP fusion protein
A DNA fragment consisting of the GFP±kanMX6 cassette with
short-flanking regions that were homologous with the JEN1
locus at the  3«-end of the ORF was produced by PCR. S.
Figure 1 Strategies followed for the construction of the JEN1–GFP fusion (A) and for the verification of gene fusion by analytical PCR (B)
(A) Primers S1 and S2 were used to amplify a GFP-kanMX6 cassette. Primer S1 was homologous with the last 46 nt of JEN1, and primer S2 was homologous with the first 45 nt downstream of
JEN1. After transformation of the CEN.PK 113-5D strain with the PCR product, a strain named BLC491-U2 was obtained, bearing the Jen1±GFP fusion protein. (B) Cells from single colonies of
BLC491-U2 (JEN1–GFP ) and of CEN.PK 113-5D (WT) were lysed as described in the Materials and methods section. Of the cell suspension of each strain, 1 ll was used directly for PCR
analysis according to the previously described strategy. The PCR products were loaded on to a 0.7 % (w/v) agarose gel, and the size of the fragments obtained are indicated in the Figure.
cerevisiae strain CEN.PK113-5D was transformed with this PCR
product to yield the chimaeric JEN1±GFP gene (Figure 1A). The
correct fusion of the targeted gene at the genomic locus was
verified by analytical PCR performed on whole cells. The primers
used to confirm the correct fusion are summarized in Table 2,
and shown in Figure 1(B). Six independent PCRs were performed,
with three of them using the strain CEN.PK113-5D as a control
and primer pairs A1 and A2, A1 and K2, and A2 and K3. Using
the same primers, three PCRs were performed using the strain
BLC491-U2, bearing the JEN1±GFP fusion. The analytical PCR
results clearly confirmed that the PCR-generated DNA fragment
was correctly integrated into the CEN.PK113-5D genomic JEN1
locus.
Jen1 fused with GFP is a functional lactate transporter
De-repressed cells of the strains CEN.PK113-5D and BLC491-
U2 were obtained under the conditions described in the Materials
and methods section, and after 4 h in YNB/lactic acid medium
the cells were analysed for their capacity to transport labelled
lactic acid. The results obtained at pH 5.0 are presented in Figure
2, showing that both strains display activity for the lactate
permease. The kinetic parameters observed were of the same
order of magnitude : for the CEN.PK113-5D strain, Vmax was esti-
mated to be 0.28 nmol/s per mg of dry mass, and Km was
estimated to be 0.44 mM; for the BLC491-U2 strain, Vmax
was estimated to be 0.30 nmol/s per mg of dry mass, and
Km was estimated to be 0.49 mM. Under the same experimental
conditions, transport of labelled lactic acid was evaluated in cells
not expressing JEN1 (strain CEN.PK 113-13D-Djen1). In this
strain, the initial uptake rates were significantly lower than those
observed in cells expressing JEN1. Furthermore, first-order
kinetics were found, indicative of the absence of a mediated
transport mechanism for the acid across the plasma membrane
(Figure 2). Cells of the strain W303-1a, obtained under identical
experimental conditions [1], displayed similar kinetic parameters:
Figure 2 Initial uptake rates of labelled lactic acid at pH 5.0 by YNB/lactic
acid-derepressed cells of various yeast strains
Shown are the results of experiments performed with strains CEN.PK 113-5D (E), BLC491-
U2 (D) and CEN.PK 113-13D-Djen1 (+). Uptake studies were performed as described in the
Materials and methods section. Cells that were growing exponentially in YNB-glucose were
harvested by centrifugation, washed twice with deionized water, and incubated in YNB-lactate
for 4 h before the transport assay.
a Vmax of 0.40 nmol/s per mg of dry mass and a Km of 0.69 mM.
Cultures of strains CEN.PK113-5D and BLC491-U2 were grown
in YNB-glucose and YNB-lactic acid liquid and solid media.
After 48 h, no differences were found between them in terms of
the final biomass or the growth rates.
Jen1–GFP is localized in the plasma membrane
The expression and subcellular localization of Jen1±GFP fusion
protein was monitored over time in living cells by fluorescence
microscopy. BLC491-U2 cells were grown overnight in YNB-
glucose medium until they reached a D'!! of approx. 0.5, and
Figure 3 Photographs of a time-course study showing the localization of fluorescent JEN1–GFP in living cells
Cells growing exponentially in YNB-glucose were harvested by centrifugation, washed twice with deionized water, and incubated in YNB-lactate. Equal volumes of cells were resuspended in low-
melt agarose and observed by epifluorescence microscopy. Photos were then taken at the times indicated.
Figure 4 Time course of JEN1–GFP inactivation
(A) Induced cells of the BLC491-U2 strain were treated with glucose or with sorbitol (as a control for osmotic shock), to a final concentration of 110 mM, and examined after continued incubation.
(B) Induced cells of the BLC491-U2 strain were examined after 1 h of glucose treatment (final concentration 110 mM) and stained with CMAC-arginine, either detecting GFP fluorescence or CMAC-
arginine fluorescence [17]. CMAC-arginine is a vacuole-specific stain. PC, phase contrast.
were subsequently transferred to YNB medium containing lactic
acid [0.5 % (w/v) at pH 5.0] as the sole carbon and energy source.
After relocating the cells to medium with lactic acid, the
expression and localization of Jen1±GFP, the lactic acid con-
centration and the attenuance of the culture were measured
simultaneously over a  24 h period. In Figure 3, representative
photographs of Jen1±GFP fluorescence in cells at various time
points are shown. The fluorescence was almost undetectable
within the first  2 h. After that, it started to become clearly
localized to the plasma membrane, and increased gradually. The
maximum fluorescence intensity in the plasma membrane was
achieved 4±6 h after induction of the medium with lactic acid.
Figure 5 Jen1–GFP localization in a secretory mutant
Jen1±GFP expression was induced in the BLC492 strain. BLC492 strain was derived from the parental cross between BLC491-U2 strain and a sec6-1 strain with a temperature-sensitive defect in
fusion of the secretory vesicles with the plasma membrane. Cells were induced in YNB-containing lactic acid (0.5 %, v/v, pH 5.0) for 4 h at the permissive temperature (23 °C) or at the restrictive
temperature (37 °C). After this assay, the cells induced at the restrictive temperature were treated with 10 lg/ml cycloheximide, and incubated at 23 °C for a further 2 h.
After a prolonged incubation, the signal was lost from the
plasma membrane, and the Jen1±GFP fusion protein began to be
internalized by endocytosis, and was subsequently delivered to
the vacuole. The metabolite content present in the medium
culture was examined by HPLC, and it was found that con-
sumption of lactic acid occurred during the whole experiment
(results not shown).
Catalytic-centre activity of the Jen1–GFP lactate transporter Light
absorption and fluorescence emission spectra were recorded from
cell suspensions expressing JEN1 or JEN1±GFP. The specific
fluorescence of purified GFP is indistinguishable from
membrane protein±GFP fusions in Vivo (A. Kruckeberg, un-
published results). The fluorescent signal from Jen1±GFP was
used to determine the cellular concentration and catalytic-centre
activity of the fusion protein, using purified GFP as a fluorescent
standard. The cellular abundance of the Jen1±GFP chimaera
proved to be in 1670 molecules/cell, and the estimated value for
the catalytic-centre activity was  123 s ". All the fluorescence
signal appeared to reside at the plasma membrane in the cells
expressing JEN1±GFP, when examined by fluorescence micro-
scopy (results not shown).
Inactivation of Jen1–GFP by glucose
Cells of the strain BLC491-U2 induced with lactate were treated
with glucose or sorbitol (final concentration  110 mM), and
examined after a continued period of incubation (Figure 4A). In
glucose-treated cells, after 5 min the fluorescent signal was almost
completely lost from the plasma membrane, and appeared in
punctuate structures. After 30 min of incubation, it accumulated
in a single, large globular structure. In sorbitol-treated cells, the
fluorescence remained in the plasma membrane. To identify
the globular structure observed in cells after 30 min of glucose
addition, the cells were incubated with CMAC-Arg, which stains
the vacuole [17]. The GFP fluorescence clearly co-localized with
vacuoles stained by CMAC-Arg (Figure 4B).
Jen1–GFP is targeted to the plasma membrane via a Sec6-
dependent process
The role of the secretory pathway in the trafficking of Jen1±GFP
to the plasma membrane was assessed in a strain with a
temperature-sensitive allele of the SEC6 gene [19,20]. The growth
of  10 complete tetrads originating from the parental cross
between the BLC491-U2 and Dsec6-4 strains was evaluated on
YPD medium, both at the permissive temperature of 23 °C and
at the restrictive temperature of  37 °C, and on YPD medium
supplemented with Geneticin. One haploid strain, BLC492, was
selected, which exhibited normal growth on YPD-geneticin,
and which was temperature-sensitive at  37 °C. When the ex-
pression of the Jen1±GFP fusion protein was induced in this
strain grown at the permissive temperature, the plasma membrane
was clearly labelled by GFP (Figure 5). When the fusion protein
was expressed in cells maintained at the restrictive temperature
of 37 °C, the fluorescence developed to a similar level, but it was
completely excluded from the plasma membrane. Instead, it
accumulated in globular bodies within the cell (Figure 5). The
sec6-4 phenotype has been reported to be reversible, when cells
are restored to the permissive temperature [19]. After sec6-4
cells expressing Jen1±GFP were shifted from the restrictive to
the permissive temperature for 2 h, their plasma membranes were
distinctly labelled with fluorescence (Figure 5). This assay was
performed in the presence of cycloheximide in order to prevent
the de no?o synthesis of protein.
Endocytosis is involved in the removal of Jen1–GFP from the
plasma membrane
Strains with the end3-1 or end4-1 alleles display temperature-
sensitive defects in endocytosis [10]. The growth of 10 complete
tetrads originating from the parental cross between BLC491-U2
and an end3-1 strain was evaluated on YPD medium, both at the
permissive temperature of 23 °C and at the restrictive temperature
of 37 °C and on YPD supplemented with Geneticin. One haploid
strain, BLC493, was selected, which exhibited normal growth on
YPD-Geneticin medium, and which was temperature-sensitive
at 37 °C. The expression of JEN1±GFP was induced for 4 h, both
in the BLC493 (end3-1) strain and in the BLC491-U2 strain at
23 °C. After 4 h, there was a clear localization of the fluorescence
to the plasma membrane in both strains (Figure 6). Each culture
was then divided into four aliquots. Two were maintained at the
permissive temperature, and two were transferred to the re-
strictive temperature. Glucose was added to one of the aliquots
to a final concentration of 2 % (w/v) at each temperature. All the
cultures were visualized by fluorescence microscopy after 30 min
(Figure 6). In the absence of glucose, there was a strong
fluorescent staining of the plasma membrane in all cultures, both
at  23 °C and at  37 °C. The addition of glucose led to an
accumulation of the fluorescence in the vacuole both in BLC491-
U2 and in BLC493 cells at the permissive temperature, but only
in BLC491-U2 cells at the restrictive temperature. In BLC493
cells at 37 °C, there was a retention of JEN1±GFP in the plasma
membrane, which persisted with prolonged incubation. Taken
together, these results indicate that, upon glucose treatment,
Figure 6 Jen1–GFP is retained in the plasma membrane in cells blocked in endocytosis
Jen1±GFP expression was induced for 4 h, in both the BLC493 and BLC491-U2 strains at 23 °C, under the conditions described in the Materials and methods section. After 4 h of induction,
each culture was divided into four aliquots. Two were maintained at the permissive temperature, and two were transferred to the restrictive temperature. Glucose was added to one of the aliquots
at each temperature to a final concentration of 2% (w/v). All the cultures were visualized by fluorescence microscopy after 1 h.
Figure 7 Western-blot analysis of Jen1–GFP protein level
The strains used were BLC491-U2 (END3 JEN1–GFP ) (lanes labelled ` A') and BLC 493 (end3
JEN1–GFP ) (lanes labelled ` B '). Detection of Jen1±GFP was performed with anti-GFP antibody.
Time after glucose addition is shown.
Jen1±GFP is endocytosed via END3, and subsequently targeted
to the vacuole.
Western blot analysis of the effect of glucose addition in cells
blocked in endocytosis
A Western blot analysis was performed using an anti-GFP
antibody. The strains BLC 491-U2 and BLC-493 were induced in
lactate for 4 h. After this period of induction, a sample of each
culture was collected and glucose was added to the culture
medium to a final concentration of 2 % (w/v). Of each culture,
two more samples were collected after 30 and 60 min of glucose
addition. Lysates containing 15 lg of protein were resolved on
an SDS/10 % polyacrylamide gel. After blotting, the degradation
products were only observed in the BLC491-U2 strain (Figure 7).
No degradation products could be observed in the strain with a
defect in the endocytic pathway, supporting the results previously
obtained by fluorescence microscopy (Figure 7).
Figure 8 Activity of the lactate transporter in induced cells upon the addition of glucose, using 1 mM of labelled lactic acid, pH 5.0
(A) Activities are shown for wild-type cells (*) and Ddoa4 cells (+). (B) Ddoa4 cells transformed with the plasmid YEp96, carrying the wild-type Ub gene, were induced in the presence (D)
or absence (E) of Cu2+. The final glucose concentration was 2% (w/v).
Overexpression of Ub partially restored endocytosis of the lactate
transporter in a Ddoa4 strain
We then set out to determine whether the Ub pathway was
involved in the endocytosis of the lactate permease upon glucose
treatment. The Doa4p Ub-isopeptidase has been shown to have a
key role in Ub-dependent degradation in Vivo [21], and a doa4
mutant has reduced levels of free Ub [21]. We used the yeast
strain MHY623 lacking the Ub protein hydrolase Doa4/Npi2.
Cultures of induced cells of MHY501 and MHY623 strains were
supplemented with glucose to a final concentration of 2 % (w/v),
and samples were collected over time to estimate the activity of
the carrier. Upon glucose treatment, the inactivation of the
carrier is substantially reduced in a Ddoa4 strain when compared
with the wild type (Figure 8A). These results suggest that the
internalization step of endocytosis of the Jen1 permease is
dependent on the Doa4 protein. The Ddoa4 phenotype can be
complemented with an overproduction of Ub [22]. This can
be achieved by transforming the mutant strain with the plasmid
YEp96. This multi-copy plasmid encodes a synthetic Ub gene
under the control of the CUP1-inducible promoter. The overex-
pression of Ub ` rescued ' the internalization of the permease in
Ddoa4 cells. However, in the presence of copper, no effect was
found, in comparison with that which was observed for the strain
Ddoa4 not transformed with YEp96 (Figure 8B).
DISCUSSION
The properties and regulation of solute transporter proteins in
Vivo have been investigated further by tagging them with the
GFP of A. ?ictoria. The analysis of a number of S. cerevisiae
solute transporter proteins as fusion proteins with GFP has been
reported previously : some of the tagged proteins are members of
sugar-transporter family [3,23]. Furthermore, the hexose trans-
porters Hxt2 [17] and Hxt7 [24], and the Pho84 phosphate
transporter [25] have been tagged with GFP. In all cases tested,
the fusion proteins retain solute transport function, with kinetics
similar to those of the wild-type protein. The genetic chimaera
formed between Jen1 and GFP is also a functional lactate
transporter. The expression pattern and intracellular trafficking
of the fusion protein, monitored by fluorimetry and epifluores-
cence microscopy, has been determined. We observed that the
protein is strongly localized at the plasma membrane in induced
cells. The maximum expression at the plasma membrane was
obtained between 4±6 h after induction, and this result was in
accordance with the results obtained previously by determining
the activity of the carrier [26].
The quantification of the emission from GFP in the Jen1±GFP
protein allowed us to estimate a value of 123 s " for the catalytic-
centre activity of the lactate transporter in Vivo. This is the first
empirical estimate of a catalytic-centre activity for a yeast
monocarboxylate transport protein. The value obtained is of the
same order of magnitude as the one obtained for the GLUT1
human glucose transporter at 37 °C [27], and for the Hxt7±GFP
transporter [24]. All of these solute permeases are high-affinity
transporters. The value obtained seems to reflect a high activity
of this transporter molecule in cells under induction conditions.
The factors involved in proper localization and turnover of the
Jen1 protein were also explored by expression of the Jen1±GFP
fusion in a set of strains with mutations affecting specific steps in
the secretory and endocytic pathways. We have shown that
SEC6 is involved in delivering Jen1±GFP to the membrane.
The results obtained in a strain defective in the END3 gene
indicate that endocytosis is the mechanism involved in the
process of catabolite inactivation of the carrier. Glucose triggers a
rapid degradation of the lactate permease in the vacuole. Upon
treatment with glucose, Jen1p was removed from the membrane,
internalized by endocytosis and accumulated in the vacuole for
degradation. The data resulting from the inactivation of Jen1±
GFP by glucose, together with the results observed in the time-
course experiments (Figure 3), indicate that the permease consti-
tutively undergoes a moderate rate of turnover, in addition to a
rapid, stress-stimulated turnover.
We used a strain defective in the Ub-protein hydrolase
Doa4/Npi to determine whether the binding of Ub was a signal
required for the internalization of the carrier. Jen1p undergoes
internalization for vacuolar degradation in a manner dependent
on Doa4p. This pattern of behaviour is also reported in the
literature for other plasma membrane proteins whose internaliza-
tion is substantially reduced in doa4 mutant cells [28±32].
The results obtained with cells featuring impairments in the
Doa4 protein showed that ubiquitination of the lactate permease
signals its endocytosis. These observations taken together re-
inforce previous evidence that indicated that there is a general
pattern in the mechanism of endocytosis followed by all the
plasma membrane proteins studied to date in yeast, as has been
suggested by Hicke [33]. The results obtained in the present study
suggest that glucose-induced proteolytic degradation (catabolite
inactivation) of Jen1p seems to occur independently of the
proteasome, i.e. it occurs in the vacuole after internalization by
glucose. Future experiments will be designed to determine the
type of ubiquitination that the Jen1p permease undergoes in S.
cerevisiae, and the mechanisms that regulate the endocytosis of
this transporter.
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